[HTML][HTML] Artificial intelligence to deep learning: machine intelligence approach for drug discovery

R Gupta, D Srivastava, M Sahu, S Tiwari, RK Ambasta… - Molecular …, 2021 - Springer
Drug designing and development is an important area of research for pharmaceutical
companies and chemical scientists. However, low efficacy, off-target delivery, time …

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

AS Rifaioglu, H Atas, MJ Martin… - Briefings in …, 2019 - academic.oup.com
The identification of interactions between drugs/compounds and their targets is crucial for
the development of new drugs. In vitro screening experiments (ie bioassays) are frequently …

From machine learning to deep learning: Advances in scoring functions for protein–ligand docking

C Shen, J Ding, Z Wang, D Cao… - Wiley Interdisciplinary …, 2020 - Wiley Online Library
Molecule docking has been regarded as a routine tool for drug discovery, but its accuracy
highly depends on the reliability of scoring functions (SFs). With the rapid development of …

[HTML][HTML] MONN: a multi-objective neural network for predicting compound-protein interactions and affinities

S Li, F Wan, H Shu, T Jiang, D Zhao, J Zeng - Cell Systems, 2020 - cell.com
Computational approaches for understanding compound-protein interactions (CPIs) can
greatly facilitate drug development. Recently, a number of deep-learning-based methods …

[HTML][HTML] Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature

Y Chang, H Park, HJ Yang, S Lee, KY Lee, TS Kim… - Scientific reports, 2018 - nature.com
In the era of precision medicine, cancer therapy can be tailored to an individual patient
based on the genomic profile of a tumour. Despite the ever-increasing abundance of cancer …

Machine learning for biologics: opportunities for protein engineering, developability, and formulation

H Narayanan, F Dingfelder, A Butté, N Lorenzen… - Trends in …, 2021 - cell.com
Successful biologics must satisfy multiple properties including activity and particular
physicochemical features that are globally defined as developability. These multiple …

[HTML][HTML] Hidden bias in the DUD-E dataset leads to misleading performance of deep learning in structure-based virtual screening

L Chen, A Cruz, S Ramsey, CJ Dickson, JS Duca… - PloS one, 2019 - journals.plos.org
Recently much effort has been invested in using convolutional neural network (CNN)
models trained on 3D structural images of protein-ligand complexes to distinguish binding …

Machine‐learning scoring functions for structure‐based virtual screening

H Li, KH Sze, G Lu, PJ Ballester - Wiley Interdisciplinary …, 2021 - Wiley Online Library
Molecular docking predicts whether and how small molecules bind to a macromolecular
target using a suitable 3D structure. Scoring functions for structure‐based virtual screening …

[HTML][HTML] DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations

AS Rifaioglu, E Nalbat, V Atalay, MJ Martin… - Chemical …, 2020 - pubs.rsc.org
The identification of physical interactions between drug candidate compounds and target
biomolecules is an important process in drug discovery. Since conventional screening …

Molecule property prediction based on spatial graph embedding

X Wang, Z Li, M Jiang, S Wang… - Journal of chemical …, 2019 - ACS Publications
Accurate prediction of molecular properties is important for new compound design, which is
a crucial step in drug discovery. In this paper, molecular graph data is utilized for property …